Sugita K - Search Results

1

Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.

Ando N, Furuichi Y, Kasai S, Tamai M, Harama D, Kagami K, Abe M, Goi K, Inukai T, Sugita K. Ando N, et al. Among authors: sugita k. Leuk Res. 2018 Dec;75:36-44. doi: 10.1016/j.leukres.2018.11.001. Epub 2018 Nov 3. Leuk Res. 2018. PMID: 30453100

2

Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.

Furuichi Y, Goi K, Inukai T, Sato H, Nemoto A, Takahashi K, Akahane K, Hirose K, Honna H, Kuroda I, Zhang X, Kagami K, Hayashi Y, Harigaya K, Nakazawa S, Sugita K. Furuichi Y, et al. Among authors: sugita k. Cancer Res. 2007 Oct 15;67(20):9852-61. doi: 10.1158/0008-5472.CAN-07-0105. Cancer Res. 2007. PMID: 17942916

3

Endoplasmic reticulum stress inducers, but not imatinib, sensitize Philadelphia chromosome-positive leukemia cells to TRAIL-mediated apoptosis.

Zhang X, Inukai T, Akahane K, Hirose K, Kuroda I, Honna H, Goi K, Kagami K, Tauchi T, Yagita H, Sugita K. Zhang X, et al. Among authors: sugita k. Leuk Res. 2011 Jul;35(7):940-9. doi: 10.1016/j.leukres.2011.03.016. Epub 2011 Apr 3. Leuk Res. 2011. PMID: 21466892

4

Diverse underlying proliferation response to growth factors in imatinib-treated Philadelphia chromosome-positive leukemias.

Nemoto A, Inukai T, Uno K, Kiyokawa N, Miyagawa Y, Takahashi K, Sato H, Akahane K, Hirose K, Honna-Oshiro H, Goi K, Kagami K, Nakazawa S, Fujimoto J, Inaba T, Sugita K. Nemoto A, et al. Among authors: sugita k. Leuk Res. 2013 Jan;37(1):93-101. doi: 10.1016/j.leukres.2012.10.001. Epub 2012 Oct 23. Leuk Res. 2013. PMID: 23099235

5

Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.

Kasai S, Furuichi Y, Ando N, Kagami K, Abe M, Nakane T, Goi K, Inukai T, Saitoh S, Ohno S, Okazaki S, Nagano O, Saya H, Sugita K. Kasai S, et al. Among authors: sugita k. Cell Death Dis. 2017 Jun 1;8(6):e2857. doi: 10.1038/cddis.2017.249. Cell Death Dis. 2017. PMID: 28569787 Free PMC article.

6

Lack of association between deletion polymorphism of BIM gene and in vitro drug sensitivity in B-cell precursor acute lymphoblastic leukemia.

Huang M, Miyake K, Kagami K, Abe M, Shinohara T, Watanabe A, Somazu S, Oshiro H, Goi K, Goto H, Minegishi M, Iwamoto S, Kiyokawa N, Sugita K, Inukai T. Huang M, et al. Among authors: sugita k. Leuk Res. 2017 Sep;60:24-30. doi: 10.1016/j.leukres.2017.06.003. Epub 2017 Jun 4. Leuk Res. 2017. PMID: 28641145

7

Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.

Tamai M, Kasai S, Akahane K, Thu TN, Kagami K, Komatsu C, Abe M, Watanabe A, Goi K, Miyake K, Inaba T, Takita J, Goto H, Minegishi M, Iwamoto S, Sugita K, Inukai T. Tamai M, et al. Among authors: sugita k. J Steroid Biochem Mol Biol. 2022 Apr;218:106068. doi: 10.1016/j.jsbmb.2022.106068. Epub 2022 Feb 4. J Steroid Biochem Mol Biol. 2022. PMID: 35124168 Free article.

8

Leukemic cells with 11q23 translocations express granulocyte colony-stimulating factor (G-CSF) receptor and their proliferation is stimulated with G-CSF.

Inukai T, Sugita K, Iijima K, Goi K, Tezuka T, Kojika S, Kagami K, Mori T, Kinoshita A, Suzuki T, O-Koyama T, Nakazawa S. Inukai T, et al. Among authors: sugita k. Leukemia. 1998 Mar;12(3):382-9. doi: 10.1038/sj.leu.2400951. Leukemia. 1998. PMID: 9529133

9

p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation.

Nakamura M, Sugita K, Inukai T, Goi K, Iijima K, Tezuka T, Kojika S, Shiraishi K, Miyamoto N, Karakida N, Kagami K, O-Koyama T, Mori T, Nakazawa S. Nakamura M, et al. Among authors: sugita k. Leukemia. 1999 Jun;13(6):884-90. doi: 10.1038/sj.leu.2401437. Leukemia. 1999. PMID: 10360377

10

The KOR-SA3544 antigen predominantly expressed on the surface of Philadelphia chromosome-positive acute lymphoblastic leukemia cells is nonspecific cross-reacting antigen-50/90 (CD66c) and invariably expressed in cytoplasm of human leukemia cells.

Sugita K, Mori T, Yokota S, Kuroki M, Koyama TO, Inukai T, Iijima K, Goi K, Tezuka T, Kojika S, Shiraishi K, Nakamura M, Miyamoto N, Karakida N, Kagami K, Nakazawa S. Sugita K, et al. Leukemia. 1999 May;13(5):779-85. doi: 10.1038/sj.leu.2401408. Leukemia. 1999. PMID: 10374883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,437 results

Search Page